Valuation: PAVmed Inc.

Market Cap 15.73M 14M 12.98M 11.76M 22.1M 1.49B 22.47M 156M 61.18M 780M 59.02M 57.79M 2.49B P/E 2026 *
-0.62x
P/E 2027 * -1.14x
Enterprise Value 15.73M 14M 12.98M 11.76M 22.1M 1.49B 22.47M 156M 61.18M 780M 59.02M 57.79M 2.49B EV / Sales 2026 *
67.7x
EV / Sales 2027 * 26.2x
Free-Float
58.56%
Yield 2026 *
-
Yield 2027 * -
1 day-0.89%
1 week-15.53%
Current month-39.57%
1 month-43.83%
3 months-61.49%
6 months-76.38%
Current year-66.33%
1 week 2.14
Extreme 2.135
2.6
1 month 2.14
Extreme 2.135
4.33
Current year 2.14
Extreme 2.135
28.44
1 year 2.14
Extreme 2.135
28.44
3 years 2.14
Extreme 2.135
146.25
5 years 2.14
Extreme 2.135
2,853
10 years 2.14
Extreme 2.135
5,454
Manager TitleAgeSince
Compliance Officer 62 01/04/2023
Chief Executive Officer 60 26/06/2014
Director of Finance/CFO 68 01/03/2019
Director TitleAgeSince
Director/Board Member 60 01/10/2014
Chairman 60 26/06/2014
Director/Board Member 71 01/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
4/2/26 A Free

Chief Technology Officer

70,000 1.0966%
4/2/26 A Free

Chief Operating Officer

110,000 1.7233%
4/2/26 A Free

Chief Executive Officer

350,000 5.4832%
Change 5-day change 1-year change 3-year change Capi.($)
-0.89%-15.53%-85.38%-98.35% 15.73M
+1.23%+3.93%+26.71%+48.40% 251B
-0.09%+1.21%+8.22%+9.57% 158B
-13.26%+3.92%-4.34%+64.32% 153B
+1.27%+5.05%-54.74%-9.10% 65.29B
+1.00%+4.57%-13.27%-9.97% 51.23B
+0.58%+5.12%+10.90%+58.22% 51.29B
+1.19%+3.48%+17.20%+27.00% 50.27B
+1.82%+1.08%+21.30%+58.80% 47.9B
+1.96%+3.28%+29.15%+74.75% 42.67B
Average -0.15%+0.32%-4.42%+22.36% 87.07B
Weighted average by Cap. -0.85%+2.64%+7.78%+37.62%

Financials

2026 *2027 *
Net sales 232K 207K 192K 174K 327K 22.03M 332K 2.3M 904K 11.53M 872K 854K 36.77M 600K 534K 495K 449K 843K 56.84M 857K 5.94M 2.33M 29.75M 2.25M 2.2M 94.89M
Net income -23.17M -20.63M -19.12M -17.32M -32.56M -2.2B -33.1M -229M -90.11M -1.15B -86.92M -85.12M -3.66B -20.15M -17.93M -16.62M -15.06M -28.31M -1.91B -28.78M -199M -78.35M -999M -75.58M -74.01M -3.19B
Net Debt - -
Projected Income Statement - Annual - PAVmed Inc.
Logo PAVmed Inc.
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates in the medical devices, diagnostics, and digital health sectors. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.
Employees
41
Date Price Change Volume
20/10/26 $2.230 -0.89% 5,962
19/10/26 $2.250 -6.64% 30,099
16/10/26 $2.410 -0.62% 12,594
15/10/26 $2.425 +5.90% 8,433
14/10/26 $2.290 -13.26% 6,369
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - PAVmed Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.250USD
Average target price
36.50USD
Spread / Average Target
+1,522.22%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PAVmed Inc.
  1. Stock Market
  2. Stocks
  3. PAVM Stock